Its announcement arrives around the heels of an analogous licensing arrangement provided in February to Adastra Labs, which had until now focused on crafting cannabis extracts. Adastra's license also lets it to supply and provide psilocybin and psilocin – hallucinogens additional typically often called magic mushrooms that make effects much like